Intercept Pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 07/29/21
Why Intercept Pharmaceuticals Stock Shed 19% of Its Value in the First Six Months of 2021The Motley Fool • 07/19/21
Intercept to Present at the Raymond James 2021 Human Health Innovation ConferenceGlobeNewsWire • 06/15/21
Intercept Announces Updated Ocaliva® (obeticholic acid) U.S. Prescribing InformationGlobeNewsWire • 05/26/21
FDA Restricts Use Of Intercept's Ocaliva In Liver Disease with Advanced Cirrhosis Citing Risk Of Serious Liver InjuryBenzinga • 05/26/21
Intercept to Present at the 2021 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/12/21
Intercept Pharmaceuticals' (ICPT) CEO Jerry Durso on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Intercept Pharmaceuticals (ICPT) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/06/21
Intercept Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/06/21
With Important Trial Results Due in June, Is This Drugmaker a Good Buy Now?The Motley Fool • 04/23/21